Trademark: 90838056
Word
MAZIE
Status Date
Wednesday, May 22, 2024
Filing Date
Tuesday, July 20, 2021
Published for Opposition
Tuesday, April 4, 2023
5 Vaccine adjuvants; Drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals
1 Active chemical and biological ingredients for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; Biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; Biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; Lipid nanoparticles for scientific, laboratory or medical research use
44 Medical services; medical information; providing a website featuring medical information
42 Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
Jul 23, 2021
New Application Entered
Sep 21, 2021
New Application Office Supplied Data Entered
Jan 31, 2022
Assigned To Examiner
Feb 4, 2022
Non-Final Action Written
Feb 4, 2022
Non-Final Action E-Mailed
Feb 4, 2022
Notification Of Non-Final Action E-Mailed
Aug 3, 2022
Teas Response To Office Action Received
Aug 3, 2022
Correspondence Received In Law Office
Aug 3, 2022
Teas/Email Correspondence Entered
Aug 31, 2022
Non-Final Action Written
Aug 31, 2022
Non-Final Action E-Mailed
Aug 31, 2022
Notification Of Non-Final Action E-Mailed
Feb 6, 2023
Teas Response To Office Action Received
Feb 6, 2023
Correspondence Received In Law Office
Feb 7, 2023
Teas/Email Correspondence Entered
Mar 1, 2023
Examiners Amendment -Written
Mar 1, 2023
Examiners Amendment E-Mailed
Mar 1, 2023
Notification Of Examiners Amendment E-Mailed
Mar 1, 2023
Examiner's Amendment Entered
Mar 1, 2023
Approved For Pub - Principal Register
Mar 15, 2023
Notification Of Notice Of Publication E-Mailed
Apr 4, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 4, 2023
Published For Opposition
May 30, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 21, 2023
Sou Teas Extension Received
Nov 21, 2023
Sou Extension 1 Filed
Nov 21, 2023
Sou Extension 1 Granted
Nov 23, 2023
Notice Of Approval Of Extension Request E-Mailed
May 22, 2024
Sou Teas Extension Received
May 22, 2024
Sou Extension 2 Granted
May 22, 2024
Sou Extension 2 Filed
May 23, 2024
Notice Of Approval Of Extension Request E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
